Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Healthcare Diagnostics & Research
Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure... see more

Recent & Breaking News (TSXV:AVCR)

VANC Pharmaceuticals Receives NPNs From Health Canada For 4 Products

Marketwired November 19, 2014

Microcap Report: Vanc Pharma (V.NPH) active on Health Canada news

Stockhouse Editorial November 18, 2014

Vanc Pharmaceuticals (V.NPH) secures Health Canada approval for 22 generic molecules

Stockhouse Editorial November 18, 2014

Vanc Pharmaceuticals Receives Health Canada Approval for 22 Generic Molecules

Marketwired November 18, 2014

Vanc Pharmaceuticals Inc.: OTC Name Change in Effect

Marketwired September 16, 2014

NUVA Announces Licensing Agreements for 48 Generic Drugs for Canadian Markets

Marketwired April 16, 2014